Dr. James Rosenzweig joins RTI Health Solutions adding expertise in diabetes, endocrinology, and clinical drug development

Share on: 
James Rosenzweig

RESEARCH TRIANGLE PARK, NC — James (Jamie) Rosenzweig, MD, has joined RTI Health Solutions (RTI-HS), a business unit of RTI International, as senior director of clinical consulting. In his new role, Rosenzweig serves as an internal consultant for projects that require diabetes, endocrinology, or internal medicine expertise as well as a consultant for companies that develop pharmaceutical and medical device products to treat diseases in those areas. 

Prior to joining RTI-HS, Rosenzweig was the director of diabetes services and associate professor of Medicine at Boston University School of Medicine. In that role, he led the clinical programs for patients with diabetes at Boston Medical Center and its affiliated community health centers. He was also involved in the development and testing of programs in the Boston area and across the nation to help primary care physicians improve the care of their patients with diabetes.

As an expert endocrinologist, Rosenzweig brings with him extensive experience in clinical trials. Most notably, he served as an investigator in the pivotal Diabetes Control and Complications Trial and the follow-on Epidemiology of Diabetes Interventions and Complications study. These studies are among the most highly-cited and influential diabetes clinical studies. 

Rosenzweig has led and co-created disease management guidelines on the national level. He chaired the working group that published Clinical Practice Guideline for Primary Prevention of Cardiovascular Disease and Type 2 Diabetes in Patients at Metabolic Risk in 2008 for the Endocrine Society and is again chairing the working group to revise and update these guidelines.

Further, Rosenzweig has helped establish physician performance measurement by chairing the Performance Measures Subcommittee of the Endocrine Society and serving as a member of the Clinical Affairs Core Committee. In addition, he chairs the Endocrine Steering Committee of the National Quality Forum whose aim is to improve health and care quality through measurement. Rosenzweig has also led the development of diabetes, androgen deficiency, and thyroid nodule performance measurement sets used in Performance Improvement Modules for recertification of endocrinologists and internists by the American Board of Internal Medicine.

Rosenzweig is highly published with over 40 peer-reviewed journal articles and more than 50 book chapters, editorials, abstracts, and critical reviews. He has a doctorate of medicine from Yale School of Medicine, a bachelor's degree from Yale University, and completed post-doc training at the National Institutes of Health.

Related Services: